Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
Date:11/6/2012

. BELVIQ® is a registered trademark of Arena Pharmaceuticals GmbH.

Forward-Looking Statements Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the advancement, therapeutic indication and use, safety, efficacy, mechanism of action, regulatory review and approval, DEA scheduling, launch, commercialization and potential of BELVIQ; pursuing and entering into additional collaborations; rights, obligations, expectations and future activities related to the marketing and supply agreements with Eisai and Ildong; decisions of EU and Swiss regulatory authorities on marketing applications; delivering value to stockholders; executing on the potential of BELVIQ; providing a novel treatment to patients; advancing APD811 and other drug candidates; the therapeutic indication and use, safety, efficacy, tolerability, mechanism of action and potential of APD811, including the protocol and other aspects of the Phase 1 multiple-dose clinical trial; BELVIQ's patent coverage; and Arena's efforts, focus, goals, strategy, research and development programs, and ability to discover and develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: risks related to commercializing drugs, including regulatory, manufacturing and supply issues and the pace of market acceptance; cash and revenues generated from BELVIQ, including the impact of competition; the timing and outcome of regulatory review is uncertain; government and commercial reimbursement and pricing decisions; risks related to relying on collaborative arrangements; the timin
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Tuesday, November 6
2. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
4. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
5. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
6. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
7. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
8. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
9. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
10. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
11. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Conn. , Aug. 21, 2014  Aptuit ... West Lafayette, Indiana , has enhanced ... and characterization of small and large molecules, including ... of the Bruker maXisPlus Q-TOF mass spectrometer. ... Goldman , CEO, Aptuit, said, "The expanded large ...
(Date:8/21/2014)... 21, 2014   Memorial Hermann Health System and ... today announced a new partnership to provide a new level ... care centers in the greater Houston ... become the exclusive provider of professional breast radiology services for ... Memorial City, The Woodlands , Northeast, Southwest ...
(Date:8/21/2014)... AUSTIN, Texas , Aug. 21, 2014  Vermillion, ... company focused on gynecologic cancers and women,s health, has ... of Sales and Managed Markets. Ms. Bauzon ... traction and expanding payer coverage for laboratory services companies. ... most recently with PerkinElmer, Inc., where she held the ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... 2011 Theramed Corporation ("Theramed") announces that ... Clinical Meeting of the Society of Obstetricians and Gynecologists ... to be used to advance the practice of obstetrics, ... have been approved for sale by Health Canada, and ...
... 14, 2011 Viral Genetics, Inc. (Pinksheets: VRAL) ... company. The Company,s two lead pharmaceutical programs -- ... compounds for drug-resistant cancers -- are being advanced ... New Drug (IND) pathways. An IND application is ...
Cached Medicine Technology:Theramed Corporation to Launch Glenveigh Products, ebb™ and jetty™ at the Society of Obstetricians and Gynecologists of Canada 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 3Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 4
(Date:8/21/2014)... Os-Monitor.com, an outstanding online supplier ... employee monitoring software collection ( http://www.os-monitor.com ). In ... that all these high end items are offered ... tendency of improving productivity, the employers pay more ... Thus, employee and network monitoring software products are ...
(Date:8/21/2014)... New York (PRWEB) August 22, 2014 ... for the Long Island region, proudly announces the launch ... site, focused on the West Babylon-based yoga studio’s new ... who wish to become teachers realize their dreams. , ... community and those living in the surrounding area a ...
(Date:8/21/2014)... August 22, 2014 The natural loss of ... lines, wrinkles and sagging of skin. Using products to ... age 40, the body has lost about 15% of it ... 45%," says Kathy Heshelow, founder of Sublime Beauty®. "Collagen ... it - well, we know what happens." , Collagen in ...
(Date:8/21/2014)... 2014 Strongly influenced by their ... when there are no consequences, researchers in Georgia ... , This could imply that humans are less ... others, researchers said. Their findings are published in ... sense of unfairness is affected by their self-interest, ...
(Date:8/21/2014)... Top10BestSEOHosting.com has compared many professional SEO hosting companies and ... most reliable suppliers for webmasters who want to buy ... in websites in recent years, and the new demand ... web hosting companies that offer a variety of different ... providing hosting solutions to thousands of business and personal ...
Breaking Medicine News(10 mins):Health News:New Employee Monitoring Software Collection Unveiled By Os-Monitor.com 2Health News:Yoga Darshana Center Announces Launch of New Website LongIslandYogaTeacherTraining.com 2Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 2Health News:4 Skincare Products That Boost and Nurture Collagen on Sale at Sublime Beauty® 3Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 3Health News:Best SEO Hosting Suppliers in the Global Market Recommended by Top10BestSEOHosting.com 2
... The American Lung Association of the Upper Midwest shares the ... flooding in several states that we serve. Because flood water ... thousands of people with lung disease, and may cause lung ... these tips. For more specific help on cleaning up after ...
... Globus Medical, Inc., the largest privately held ... the launch of MicroFuse(TM) ST Granules, a unique ... strength and porosity. MicroFuse(TM) technology utilizes proprietary combinations ... manufactured with a patented microsphere process to deliver ...
... medicine to standard therapy made the difference, researchers ... People with cancer of the larynx who ... to keep their larynx than those who received ... study compared treatment with a combination of three ...
... Study finds procedure dramatically reduces transmission of herpes, human ... decision of whether or not to circumcise an infant ... that having the procedure may reduce the risk of ... of more than 5,000 uncircumcised adult Ugandan males, researchers ...
... Bipartisan Group Led by Former Rep. Gephardt Underscores ... Finding Cures for Life-Threatening Diseases , WASHINGTON, March ... applauds President Obama on his support for improving ... costs through continued scientific and technological advancements. (Logo: ...
... of Biology, Geology and Nursing, and Director of the MS ... Islands , was recently awarded a grant of $1,733,406 from ... of their Bridges to Stem Cell Research program. CSUCI was ... program. , , "We are thrilled to have ...
Cached Medicine News:Health News:American Lung Association of Upper Midwest Offers Tips on Dealing With Floodwaters 2Health News:American Lung Association of Upper Midwest Offers Tips on Dealing With Floodwaters 3Health News:Globus Medical's MicroFuse(TM) Technology Engineered for Optimal Strength and Porosity 2Health News:Drug Combo Helps Larynx Cancer Patients Preserve Voice Box 2Health News:Circumcision Guards Against STDs 2Health News:Circumcision Guards Against STDs 3Health News:Council for American Medical Innovation Applauds President Obama for Calling for 'Serious Investments in Science and Technology' 2Health News:CSUCI Receives $1.7 Million Grant for Stem Cell Research Program 2Health News:CSUCI Receives $1.7 Million Grant for Stem Cell Research Program 3
Representing the next step in the evolution of point-of-care testing, the i-STAT 1 Analyzer uses one platform to perform glucose strip testing along with all i-STAT test cartridges....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
... Extremely bright xenon ... headlight or other instruments. ... other fiber optic cables. ... certification. Convenient lamp change ...
Provides surgeon's eye view of any procedure. View procedures live or edit tapes or digital files for later use. Extended field-of-vision maintains sharp focus from 8" to 36". Automatic Iris and Gain...
Medicine Products: